Tag Archives: MiMedx Group

Needham Believes MiMedx Group (NASDAQ: MDXG) Won’t Stop Here

Needham analyst Michael Matson reiterated a Buy rating on MiMedx Group (NASDAQ: MDXG) yesterday and set a price target of $15. The company’s shares closed yesterday at $11.53, close to its 52-week high of $12.16. Matson wrote: “We hosted a

MiMedx Group Gets a Buy from Needham

In a report released today, Michael Matson from Needham reiterated a Buy rating on MiMedx Group (NASDAQ: MDXG), with a price target of $15. The company’s shares opened today at $9.98. Matson noted: “This morning, MDXG preannounced 1Q17 revenue of

Needham Releases a Buy Rating on MiMedx Group

In a report released today, Michael Matson from Needham reiterated a Buy rating on MiMedx Group (NASDAQ: MDXG), with a price target of $12. The company’s shares opened today at $8.29. Matson commented: “MDXG’s 4Q16 revenue was below its 1/9/17

Analysts Offer Insights on Healthcare Companies: MiMedx Group (NASDAQ: MDXG) and Cytori Therap. (NASDAQ: CYTX)

There’s a lot to be optimistic about in the Healthcare sector as 2 experts just weighed in on MiMedx Group (NASDAQ: MDXG) and Cytori Therap. (NASDAQ: CYTX) with bullish sentiments. MiMedx Group (NASDAQ: MDXG) Needham analyst Michael Matson reiterated a

The Chairman & CEO of MiMedx Group (NASDAQ: MDXG) is Buying Shares

Today, the Chairman & CEO of MiMedx Group (NASDAQ: MDXG), Parker Petit, bought shares of MDXG for $139.8k. In addition to Parker Petit, 8 other MDXG executives reported Buy trades in the last month. Over the last month, Parker Petit

The Chairman & CEO of MiMedx Group (NASDAQ: MDXG) is Buying Shares

Today, the Chairman & CEO of MiMedx Group (NASDAQ: MDXG), Parker Petit, bought shares of MDXG for $204.6k. Based on MiMedx Group`s latest earnings report from March 31, the company posted quarterly revenue of $53.37M and quarterly net profit of